Arkolith/Insider Trading/GRTX/Form 4

Sorensen Mel

President and CEO, DirectorGalera Therapeutics, Inc. (GRTX) · full profile →Form 4 · filed Nov 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2025Sell(S)70K$0.02$1K195K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-004171) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML